This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

2020 PROGRAM

Sunday, March 1, 2020

7:00 - 8:00 AM
CASL Special Interest Group Meetings

7:00 - 7:30 AM
CAHN Breakfast

7:30 - 9:30 AM
CAHN AGM

8:00 - 9:00 AM

SYMPOSIUM (BEST OF AASLD)

Hemant Shah, UHN

  • NAFLD, Giada Sebastiani, McGill University
  • Portal Hypertension / Cirrhosis, Andrew Aronsohn, University of Chicago
  • Alcohol, Phillipe Mathurin, INSERM
  • HCV, Amit Singal, UT Southwestern Liver Centre

9:00 - 10:30 AM
ORAL ABSTRACT PRESENTATION

Keith Tsoi, McMaster University & Cynthia Tsien, University of Ottawa

  • Women Likely to Benefit from Having a Potential Living Liver Donor Compared to Men, Mamatha Bhat, UHN
  • Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis, Gideon Hirschfield, UHN
  • Preventive Effect of Celecoxib in Sorafenib-Related Hand-Foot Syndrome in Hepatocellular Carcinoma Patients, a Single-Center, Open-Label, Randomized, Controlled Clinical Phase III Trial, Jiancong Chen, First Affiliated Hospital, Sun Yat-Sen University
  • Noninvasive Tests (NITs) May More Accurately Quantify Fibrosis than Liver Histology in Patients with Advanced Fibrosis Due to NASH, Keyur Patel, UHN
  • Health-Related Quality of Life – a Rapid Independent Predictor of Hospitalizations and Mortality in Cirrhosis, Beverley Kok, University of Alberta Hospital
  • Hemojuvelin Deficiency Predisposes Mice to Hepatocellular Carcinoma, Kostas Pantopoulos, Lady Davis Institute for Medical Research/McGill University

10:30 - 10:45 AM
Coffee Break & Poster Sessions

10:45 - 12:25 PM
SYMPOSIUM ‑ STATE OF THE ART: HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

Adam Gehring, UHN & Ebehard Renner, University of Manitoba

  • Differences in Clonal Evolution of Recurrent Hepatocellular Carinoma Depending on the Immune Environment, Mamatha Bhat, UHN
  • Current Status of Liver Transplantation for Cholangiocarcinoma/ Colorectal Metastases, Peter Metrakos, McGill University, Montreal, Canada
  • Oncolytic Viruses for Cancer Immunotherapy, Shashi Gujar, Dalhousie University
  • Barriers and Controversies in HCC Surveillance, Amit Singal, UT Southwestern Liver Centre
  • Systemic Therapy in HCC, Adrian di Bisceglie

12:25 - 1:15 PM
Gold Medal Lecture

1:15 - 1:45 PM
Closing Remarks and Awards